BOUDREAUX GAIL 4
4 · Elevance Health, Inc. · Filed Jul 18, 2025
Insider Transaction Report
Form 4
BOUDREAUX GAIL
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2025-07-18$287.12/sh+5,116$1,468,906→ 149,970 total - Purchase
Common Stock
2025-07-18$287.96/sh+1,050$302,358→ 151,020 total - Purchase
Common Stock
2025-07-18$286.07/sh+2,334$667,687→ 144,854 total
Holdings
- 60(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]This transaction was executed in multiple purchases at prices ranging from $285.50 to $286.43. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple purchases at prices ranging from $286.70 to $287.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple purchases at prices ranging from $287.72 to $288.14. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.